Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019
Diabetes, Obesity and Metabolism · 2023-04 · 25 (S1) · 43-52
DOI: 10.1111/dom.15010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 07.03.2023. Verfasst von Huixin Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
To assess the burden of liver complications related to non‐alcoholic fatty liver disease (LC‐NAFLD) from 2005 to 2019 in China. Materials and Methods We used data from the Global Burden of Disease, Injuries, and Risk Factors Study, 2019, to present contemporary and varying profiles of China's LC‐NAFLD burden. The Joinpoint Regression model and Gaussian process regression were, respectively, used to estimate the annual percentage change in prevalence rates and disability‐adjusted life‐year (DALY) rates, and the relationship between the sociodemographic index (SDI) and age‐standardized rates of LC‐NAFLD.
Results
In 2019, China had 293.42 million (95% uncertainty interval [UI]: 263.69‐328.44) LC‐NAFLD cases with a prevalence rate and DALYs of 20.63 (95% UI: 23.09‐18.54) per 1000 people and 591.03 thousand (95% UI: 451.25‐737.33), respectively. North China had the highest prevalence but the lowest DALYs of LC‐NAFLD, whereas Southwest China had the lowest prevalence but the highest DALYs. LC‐NAFLD were more common in men than in women (male: female ratio, 1.27) in 2019. From 2005 to 2019, the prevalence of NAFLD cases increased by 68.32% (from 174.32 million in 2005 to 293.42 million in 2019), mainly because of an age‐specific prevalence rate increase.
Conclusion
The LC‐NAFLD burden in China is substantial and has increased markedly over the past 15 years. Effective measures for low SDI regions and men are needed to address the rapidly increasing NAFLD burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, Beijing, China.
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology…
- Department of Global Health, School of Public Health, Peking University, Beijing, China.
- Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Huixin Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Qi, J., Yang, J., Liu, F., Li, X., Yin, P., Wang, L., Liang, Z., Wei, L., Rao, H., & Zhou, M. (2023). Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019. Diabetes, Obesity and Metabolism, 25(S1), 43-52. https://doi.org/10.1111/dom.15010
Vancouver
Liu H, Qi J, Yang J, Liu F, Li X, Yin P, et al. Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019. Diabetes, Obesity and Metabolism. 2023;25(S1):43-52. doi:10.1111/dom.15010
BibTeX
@article{Liu2023,
author = {Liu, Huixin and Qi, Jinlei and Yang, Jia and Liu, Feng and Li, Xiaohe and Yin, Peng and Wang, Lijun and Liang, Zhisheng and Wei, Lai and Rao, Huiying and Zhou, Maigeng},
title = {Burden of liver complications related to non‐alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019},
journal = {Diabetes, Obesity and Metabolism},
year = {2023},
volume = {25},
number = {S1},
pages = {43--52},
doi = {10.1111/dom.15010}
}
EUVIMED